Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny patch tracks drug side effects on Seniors' gait

NCT ID NCT06665685

Knowledge-focused Sponsor: Charles Lin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small pilot study tested whether a wearable device called BioButton could help detect walking problems caused by multiple medications in nursing home residents. Only 17 people took part before the study was stopped early. The goal was to see if the device was safe and easy to use, not yet to prove it improves health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BioButton wearable device
What this could lead to
If successful, this approach could help doctors adjust medications to reduce fall risk in older adults.
What could go wrong
The study was terminated early and very small (17 people), so results are limited. It only tested feasibility, not whether it actually prevents falls.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

17 people

The number who actually took part.

Started

Mar 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \>18yrs * Presence of gait documentation in EMR Exclusion Criteria: * Age \<18yrs * Non-English-speaking patients * Patients who cannot provide consent due to cognitive status * Bedbound, unable to stand

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GAIT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gait apraxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GAIT Medication induced gait disturbances

Contacts and locations

Locations

  • UPMC Canterbury Place

    Pittsburgh, Pennsylvania, 15201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.